MHT CET CAP 2026: The Maharashtra State Common Entrance Test (MHT CET) Cell has announced the schedule for the Centralized ...
Rajasthan CET Graduate Level 2026: Rajasthan Staff Selection Commission has officially released the notification of the CET ...
(UroToday.com) The 2026 American Society of Clinical Oncology Genitourinary (ASCO) Annual Meeting held in Chicago, IL, was host to the Prostate, Testicular, and Penile Cancer - Rapid Oral Abstracts ...
Macworld reports that Apple’s 2026 entry-level iPad is expected to launch by May 2026 with either the A18 or A19 chip, bringing Apple Intelligence support for the first time. The upgrade appears ...
The 2026 Rivals150 player rankings have been updated for the final time. This is the eleventh and last ranking for this class, debuting a top 50 in September of 2023 and expanding that 50 to 100 in ...
Every knowledge-based profession may one day reach the point when AI outperforms the human experts. In medicine, that day appeared to come in April. A group of primarily Harvard and Stanford ...
Royal Ascot is here, and the British royal family—particularly Princess Anne’s branch of the family—showed out in full force for the first day of the horse racing event in Berkshire. The Princess ...
Abstract: Image restoration seeks to recover high-quality images from degraded inputs but becomes highly ill-posed under complex, mixed degradations. While unified all-in-one models are common, their ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. While the MBA degree is often criticized as overpriced, its true value is highly individual, ...
Researchers around the world are racing to develop new quantum-based systems for sensing, communication, computing and control that have the promise of outperforming traditional systems. Creating ...
Abstract: The convergence of embodied intelligence and world models has catalyzed growing interest in integrating physical laws into AI systems. While prior surveys have examined world models and ...
Talquetamab, a bispecific antibody targeting GPRC5D and CD3, has led to durable responses in patients with heavily pretreated relapsed or refractory multiple myeloma in phase 1–2 trials, with a ...